$INCY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INCYTE CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INCYTE CORP. Get notifications about new insider transactions in INCYTE CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 05 2021 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Sell | S | 85.40 | 396 | 33,818 | 26,940 | 27.3 K to 26.9 K (-1.45 %) |
Apr 27 2021 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 127 | 8,301 | 2,549 | |
Apr 27 2021 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 127 | 8,301 | 29,938 | 29.8 K to 29.9 K (+0.43 %) |
Apr 13 2021 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Payment of Exercise | F | 79.96 | 517 | 41,339 | 29,811 | 30.3 K to 29.8 K (-1.70 %) |
Apr 05 2021 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Sell | S | 81.57 | 396 | 32,302 | 27,336 | 27.7 K to 27.3 K (-1.43 %) |
Apr 01 2021 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 81.27 | 251 | 20,399 | 5,510 | 5.3 K to 5.5 K (+4.77 %) |
Apr 01 2021 | INCY | INCYTE CORP | HARRIGAN EDMUND | Director | Grant | A | 81.27 | 219 | 17,798 | 2,711 | 2.5 K to 2.7 K (+8.79 %) |
Apr 01 2021 | INCY | INCYTE CORP | DIXON WENDY L | Director | Grant | A | 81.27 | 225 | 18,286 | 14,878 | 14.7 K to 14.9 K (+1.54 %) |
Apr 01 2021 | INCY | INCYTE CORP | Clancy Paul J | Director | Grant | A | 81.27 | 298 | 24,218 | 5,094 | 4.8 K to 5.1 K (+6.21 %) |
Mar 31 2021 | INCY | INCYTE CORP | Morrissey Michael James | EVP, Head of Tech. ... | Sell | S | 81.08 | 20,000 | 1,621,600 | 45,452 | 65.5 K to 45.5 K (-30.56 %) |
Mar 16 2021 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 128 | 8,366 | 2,676 | |
Mar 16 2021 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 128 | 8,366 | 30,328 | 30.2 K to 30.3 K (+0.42 %) |
Mar 03 2021 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Sell | S | 79.73 | 395 | 31,493 | 27,732 | 28.1 K to 27.7 K (-1.40 %) |
Feb 23 2021 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Buy | P | 77.37 | 12,925 | 1,000,007 | 284,231 | 271.3 K to 284.2 K (+4.76 %) |
Feb 23 2021 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Buy | P | 77.37 | 12,925 | 1,000,007 | 284,231 | 271.3 K to 284.2 K (+4.76 %) |
Feb 18 2021 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 127 | 8,301 | 2,804 | |
Feb 18 2021 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 127 | 8,301 | 30,200 | 30.1 K to 30.2 K (+0.42 %) |
Feb 03 2021 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Option Exercise | M | 65.42 | 961 | 62,869 | 30,759 | |
Feb 03 2021 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Sell | S | 90.00 | 395 | 35,550 | 28,127 | 28.5 K to 28.1 K (-1.38 %) |
Feb 03 2021 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Sell | S | 90.00 | 961 | 86,490 | 28,522 | 29.5 K to 28.5 K (-3.26 %) |
Feb 03 2021 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Buy | M | 65.42 | 961 | 62,869 | 29,483 | 28.5 K to 29.5 K (+3.37 %) |
Jan 27 2021 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Option Exercise | M | 73.21 | 19,986 | 1,463,175 | 0 | |
Jan 27 2021 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Option Exercise | M | 73.21 | 1,559 | 114,134 | 0 | |
Jan 27 2021 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Sell | S | 100.00 | 19,986 | 1,998,600 | 143,784 | 163.8 K to 143.8 K (-12.20 %) |
Jan 27 2021 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Buy | M | 73.21 | 19,986 | 1,463,175 | 163,770 | 143.8 K to 163.8 K (+13.90 %) |
Jan 27 2021 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Sell | S | 100.00 | 1,559 | 155,900 | 143,784 | 145.3 K to 143.8 K (-1.07 %) |
Jan 27 2021 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Buy | M | 73.21 | 1,559 | 114,134 | 145,343 | 143.8 K to 145.3 K (+1.08 %) |
Jan 27 2021 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Option Exercise | M | 68.62 | 3,795 | 260,413 | 8,539 | |
Jan 27 2021 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Sell | S | 100.00 | 3,795 | 379,500 | 119,744 | 123.5 K to 119.7 K (-3.07 %) |
Jan 27 2021 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Buy | M | 68.62 | 3,795 | 260,413 | 123,539 | 119.7 K to 123.5 K (+3.17 %) |
Jan 27 2021 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Option Exercise | M | 72.86 | 4,116 | 299,892 | 0 | |
Jan 27 2021 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Sell | S | 99.00 | 1,000 | 99,000 | 26,158 | 27.2 K to 26.2 K (-3.68 %) |
Jan 27 2021 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Sell | S | 99.00 | 4,116 | 407,484 | 27,158 | 31.3 K to 27.2 K (-13.16 %) |
Jan 27 2021 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Buy | M | 72.86 | 4,116 | 299,892 | 31,274 | 27.2 K to 31.3 K (+15.16 %) |
Jan 27 2021 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Sell | S | 100.00 | 2,744 | 274,400 | 49,994 | 52.7 K to 50 K (-5.20 %) |
Jan 27 2021 | INCY | INCYTE CORP | Morrissey Michael James | EVP, Head of Tech. ... | Payment of Exercise | F | 100.50 | 78 | 7,839 | 65,452 | 65.5 K to 65.5 K (-0.12 %) |
Jan 27 2021 | INCY | INCYTE CORP | Dickinson Jonathan Elliott | EVP, General Manage ... | Payment of Exercise | F | 100.50 | 78 | 7,839 | 27,135 | 27.2 K to 27.1 K (-0.29 %) |
Jan 25 2021 | INCY | INCYTE CORP | INCYTE CORP | 10% Owner | Grant | A | 24.75 | 350,000 | 8,662,500 | 3,550,000 | 3.2 M to 3.6 M (+10.94 %) |
Jan 25 2021 | INCY | INCYTE CORP | INCYTE CORP | 10% Owner | Grant | A | 24.75 | 350,000 | 8,662,500 | 3,550,000 | 3.2 M to 3.6 M (+10.94 %) |
Jan 20 2021 | INCY | INCYTE CORP | Stamoulis Christiana | EVP & Chief Financi ... | Option Exercise | A | 90.56 | 12,743 | 1,154,006 | 12,743 | |
Jan 20 2021 | INCY | INCYTE CORP | Stamoulis Christiana | EVP & Chief Financi ... | Grant | A | 0.00 | 11,522 | 0 | 33,821 | 22.3 K to 33.8 K (+51.67 %) |
Jan 20 2021 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Option Exercise | A | 90.56 | 12,743 | 1,154,006 | 12,743 | |
Jan 20 2021 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Grant | A | 0.00 | 11,522 | 0 | 143,784 | 132.3 K to 143.8 K (+8.71 %) |
Jan 20 2021 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Option Exercise | A | 90.56 | 12,743 | 1,154,006 | 12,743 | |
Jan 20 2021 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Grant | A | 0.00 | 11,522 | 0 | 52,738 | 41.2 K to 52.7 K (+27.96 %) |
Jan 20 2021 | INCY | INCYTE CORP | Morrissey Michael James | EVP, Head of Tech. ... | Payment of Exercise | F | 93.96 | 174 | 16,349 | 65,530 | 65.7 K to 65.5 K (-0.26 %) |
Jan 20 2021 | INCY | INCYTE CORP | Morrissey Michael James | EVP, Head of Tech. ... | Grant | A | 0.00 | 5,761 | 0 | 65,704 | 59.9 K to 65.7 K (+9.61 %) |
Jan 20 2021 | INCY | INCYTE CORP | Morrissey Michael James | EVP, Head of Tech. ... | Grant | A | 0.00 | 11,522 | 0 | 59,943 | 48.4 K to 59.9 K (+23.80 %) |
Jan 20 2021 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Option Exercise | A | 90.56 | 2,534 | 229,479 | 2,534 | |
Jan 20 2021 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Grant | A | 0.00 | 4,032 | 0 | 28,427 | 24.4 K to 28.4 K (+16.53 %) |
Jan 20 2021 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Option Exercise | A | 90.56 | 2,534 | 229,479 | 2,534 | |
Jan 20 2021 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Grant | A | 0.00 | 4,032 | 0 | 28,427 | 24.4 K to 28.4 K (+16.53 %) |
Jan 20 2021 | INCY | INCYTE CORP | Dickinson Jonathan Elliott | EVP, General Manage ... | Payment of Exercise | F | 93.96 | 174 | 16,349 | 27,213 | 27.4 K to 27.2 K (-0.64 %) |
Jan 20 2021 | INCY | INCYTE CORP | Dickinson Jonathan Elliott | EVP, General Manage ... | Grant | A | 0.00 | 5,761 | 0 | 27,387 | 21.6 K to 27.4 K (+26.64 %) |
Jan 20 2021 | INCY | INCYTE CORP | Dickinson Jonathan Elliott | EVP, General Manage ... | Payment of Exercise | F | 93.96 | 174 | 16,349 | 27,213 | 27.4 K to 27.2 K (-0.64 %) |
Jan 20 2021 | INCY | INCYTE CORP | Dickinson Jonathan Elliott | EVP, General Manage ... | Grant | A | 0.00 | 5,761 | 0 | 27,387 | 21.6 K to 27.4 K (+26.64 %) |
Jan 20 2021 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Option Exercise | A | 90.56 | 74,720 | 6,766,643 | 74,720 | |
Jan 20 2021 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | A | 90.56 | 12,743 | 1,154,006 | 12,743 | |
Jan 20 2021 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Option Exercise | A | 90.56 | 12,743 | 1,154,006 | 12,743 | |
Jan 20 2021 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Option Exercise | A | 90.56 | 12,743 | 1,154,006 | 12,743 | |
Jan 20 2021 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Option Exercise | A | 90.56 | 12,743 | 1,154,006 | 12,743 | |
Jan 13 2021 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 127 | 8,301 | 2,931 | |
Jan 13 2021 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 127 | 8,301 | 30,073 | 29.9 K to 30.1 K (+0.42 %) |
Jan 06 2021 | INCY | INCYTE CORP | Morrissey Michael James | EVP, Head of Tech. ... | Payment of Exercise | F | 86.45 | 136 | 11,757 | 48,421 | 48.6 K to 48.4 K (-0.28 %) |
Jan 06 2021 | INCY | INCYTE CORP | Dickinson Jonathan Elliott | EVP, General Manage ... | Payment of Exercise | F | 86.45 | 136 | 11,757 | 21,626 | 21.8 K to 21.6 K (-0.62 %) |
Jan 05 2021 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 86.98 | 237 | 20,614 | 5,259 | 5 K to 5.3 K (+4.72 %) |
Jan 05 2021 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 86.98 | 237 | 20,614 | 5,259 | 5 K to 5.3 K (+4.72 %) |
Jan 05 2021 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 86.98 | 275 | 23,920 | 8,921 | 8.6 K to 8.9 K (+3.18 %) |
Jan 05 2021 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 86.98 | 275 | 23,920 | 8,921 | 8.6 K to 8.9 K (+3.18 %) |
Dec 15 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 128 | 8,366 | 3,058 | |
Dec 15 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 128 | 8,366 | 29,946 | 29.8 K to 29.9 K (+0.43 %) |
Dec 15 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 128 | 8,366 | 3,058 | |
Dec 15 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 128 | 8,366 | 29,946 | 29.8 K to 29.9 K (+0.43 %) |
Dec 14 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Payment of Exercise | F | 82.05 | 720 | 59,076 | 28,522 | 29.2 K to 28.5 K (-2.46 %) |
Nov 18 2020 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Grant | A | 0.00 | 1,232 | 0 | 156,851 | 155.6 K to 156.9 K (+0.79 %) |
Nov 18 2020 | INCY | INCYTE CORP | Stamoulis Christiana | EVP & Chief Financi ... | Grant | A | 0.00 | 1,232 | 0 | 22,299 | 21.1 K to 22.3 K (+5.85 %) |
Nov 18 2020 | INCY | INCYTE CORP | Stamoulis Christiana | EVP & Chief Financi ... | Grant | A | 0.00 | 1,232 | 0 | 22,299 | 21.1 K to 22.3 K (+5.85 %) |
Nov 18 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Grant | A | 0.00 | 1,232 | 0 | 29,818 | 28.6 K to 29.8 K (+4.31 %) |
Nov 18 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Grant | A | 0.00 | 1,232 | 0 | 41,216 | 40 K to 41.2 K (+3.08 %) |
Nov 18 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Grant | A | 0.00 | 1,232 | 0 | 29,242 | 28 K to 29.2 K (+4.40 %) |
Nov 16 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 127 | 8,301 | 3,186 | |
Nov 16 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 127 | 8,301 | 28,586 | 28.5 K to 28.6 K (+0.45 %) |
Nov 12 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Sell | S | 83.00 | 798 | 66,234 | 8,646 | 9.4 K to 8.6 K (-8.45 %) |
Nov 12 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Sell | S | 83.00 | 798 | 66,234 | 8,646 | 9.4 K to 8.6 K (-8.45 %) |
Nov 10 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Option Exercise | M | 65.42 | 961 | 62,869 | 31,720 | |
Nov 10 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Sell | S | 85.17 | 961 | 81,848 | 28,010 | 29 K to 28 K (-3.32 %) |
Nov 10 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Buy | M | 65.42 | 961 | 62,869 | 28,971 | 28 K to 29 K (+3.43 %) |
Nov 04 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Option Exercise | M | 48.44 | 20,000 | 968,800 | 0 | |
Nov 04 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Sell | S | 86.60 | 20,000 | 1,732,000 | 39,984 | 60 K to 40 K (-33.34 %) |
Nov 04 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Buy | M | 48.44 | 20,000 | 968,800 | 59,984 | 40 K to 60 K (+50.02 %) |
Oct 08 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Option Exercise | M | 65.42 | 961 | 62,869 | 32,681 | |
Oct 08 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Sell | S | 91.97 | 961 | 88,383 | 28,010 | 29 K to 28 K (-3.32 %) |
Oct 08 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Buy | M | 65.42 | 961 | 62,869 | 28,971 | 28 K to 29 K (+3.43 %) |
Oct 02 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 317 | 0 | 29,313,809 | 29.3 M to 29.3 M (0.00 %) |
Oct 02 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 317 | 0 | 2,850,042 | 2.8 M to 2.9 M (+0.01 %) |
Oct 01 2020 | INCY | INCYTE CORP | HARRIGAN EDMUND | Director | Grant | A | 89.74 | 187 | 16,781 | 2,285 | 2.1 K to 2.3 K (+8.91 %) |
Oct 01 2020 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 89.74 | 219 | 19,653 | 5,022 | 4.8 K to 5 K (+4.56 %) |
Oct 01 2020 | INCY | INCYTE CORP | HARRIGAN EDMUND | Director | Grant | A | 89.74 | 187 | 16,781 | 2,285 | 2.1 K to 2.3 K (+8.91 %) |
Oct 01 2020 | INCY | INCYTE CORP | FOUSE JACQUALYN A | Director | Grant | A | 89.74 | 219 | 19,653 | 5,022 | 4.8 K to 5 K (+4.56 %) |
Oct 01 2020 | INCY | INCYTE CORP | DIXON WENDY L | Director | Grant | A | 89.74 | 197 | 17,679 | 14,440 | 14.2 K to 14.4 K (+1.38 %) |
Oct 01 2020 | INCY | INCYTE CORP | Clancy Paul J | Director | Grant | A | 89.74 | 260 | 23,332 | 4,515 | 4.3 K to 4.5 K (+6.11 %) |
Oct 01 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 89.74 | 254 | 22,794 | 9,444 | 9.2 K to 9.4 K (+2.76 %) |
Sep 14 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 127 | 8,301 | 3,441 | |
Sep 14 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 2,193 | 143,334 | 12,865 | |
Sep 14 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 127 | 8,301 | 28,331 | 28.2 K to 28.3 K (+0.45 %) |
Sep 14 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Sell | S | 90.83 | 2,193 | 199,190 | 28,204 | 30.4 K to 28.2 K (-7.21 %) |
Sep 14 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 2,193 | 143,334 | 30,397 | 28.2 K to 30.4 K (+7.78 %) |
Sep 10 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Option Exercise | M | 65.42 | 961 | 62,869 | 33,642 | |
Sep 10 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Sell | S | 88.94 | 961 | 85,471 | 28,010 | 29 K to 28 K (-3.32 %) |
Sep 10 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Buy | M | 65.42 | 961 | 62,869 | 28,971 | 28 K to 29 K (+3.43 %) |
Aug 31 2020 | INCY | INCYTE CORP | DIXON WENDY L | Director | Option Exercise | M | 18.97 | 20,000 | 379,400 | 0 | |
Aug 31 2020 | INCY | INCYTE CORP | DIXON WENDY L | Director | Sell | S | 94.51 | 20,000 | 1,890,200 | 14,243 | 34.2 K to 14.2 K (-58.41 %) |
Aug 31 2020 | INCY | INCYTE CORP | DIXON WENDY L | Director | Buy | M | 18.97 | 20,000 | 379,400 | 34,243 | 14.2 K to 34.2 K (+140.42 %) |
Aug 12 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 128 | 8,366 | 3,568 | |
Aug 12 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 128 | 8,366 | 28,204 | 28.1 K to 28.2 K (+0.46 %) |
Aug 10 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Option Exercise | M | 65.42 | 961 | 62,869 | 34,603 | |
Aug 10 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Sell | S | 97.80 | 961 | 93,986 | 28,010 | 29 K to 28 K (-3.32 %) |
Aug 10 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Buy | M | 65.42 | 961 | 62,869 | 28,971 | 28 K to 29 K (+3.43 %) |
Jul 17 2020 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Payment of Exercise | F | 104.25 | 639 | 66,616 | 155,619 | 156.3 K to 155.6 K (-0.41 %) |
Jul 17 2020 | INCY | INCYTE CORP | Trower Paul | Principal Accountin ... | Payment of Exercise | F | 104.25 | 203 | 21,163 | 24,395 | 24.6 K to 24.4 K (-0.83 %) |
Jul 17 2020 | INCY | INCYTE CORP | SWAIN PAULA J | EVP, Human Resource ... | Payment of Exercise | F | 104.25 | 626 | 65,261 | 52,781 | 53.4 K to 52.8 K (-1.17 %) |
Jul 17 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Sell | S | 103.83 | 766 | 79,534 | 95,468 | 96.2 K to 95.5 K (-0.80 %) |
Jul 17 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Payment of Exercise | F | 104.25 | 623 | 64,948 | 96,234 | 96.9 K to 96.2 K (-0.64 %) |
Jul 17 2020 | INCY | INCYTE CORP | Hoppenot Herve | Chairman / CEO | Payment of Exercise | F | 104.25 | 2,420 | 252,285 | 264,081 | 266.5 K to 264.1 K (-0.91 %) |
Jul 17 2020 | INCY | INCYTE CORP | Flannelly Barry P | EVP & General Manag ... | Payment of Exercise | F | 104.25 | 639 | 66,616 | 39,903 | 40.5 K to 39.9 K (-1.58 %) |
Jul 14 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 127 | 8,301 | 3,696 | |
Jul 14 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Option Exercise | M | 65.36 | 127 | 8,301 | 3,696 | |
Jul 14 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 127 | 8,301 | 28,076 | 27.9 K to 28.1 K (+0.45 %) |
Jul 14 2020 | INCY | INCYTE CORP | Pasquale Maria E | EVP & General Couns ... | Buy | M | 65.36 | 127 | 8,301 | 28,076 | 27.9 K to 28.1 K (+0.45 %) |
Jul 14 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Option Exercise | M | 65.42 | 2,419 | 158,251 | 0 | |
Jul 14 2020 | INCY | INCYTE CORP | Dhanak Dashyant | EVP & Chief Scienti ... | Buy | M | 65.42 | 2,419 | 158,251 | 28,010 | 25.6 K to 28 K (+9.45 %) |
Jul 08 2020 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Sell | S | 108.56 | 475 | 51,566 | 25,926 | 26.4 K to 25.9 K (-1.80 %) |
Jul 08 2020 | INCY | INCYTE CORP | Iyengar Vijay K | EVP GPS, BD, & Lice ... | Sell | S | 107.98 | 3,120 | 336,898 | 26,401 | 29.5 K to 26.4 K (-10.57 %) |
Jul 08 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Option Exercise | M | 88.68 | 7,495 | 664,657 | 0 | |
Jul 08 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Option Exercise | M | 88.68 | 3,381 | 299,827 | 0 | |
Jul 08 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Sell | S | 108.56 | 610 | 66,222 | 96,857 | 97.5 K to 96.9 K (-0.63 %) |
Jul 08 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Sell | S | 107.99 | 3,283 | 354,531 | 97,467 | 100.8 K to 97.5 K (-3.26 %) |
Jul 08 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Sell | S | 110.04 | 7,495 | 824,750 | 100,750 | 108.2 K to 100.8 K (-6.92 %) |
Jul 08 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Buy | M | 88.68 | 7,495 | 664,657 | 108,245 | 100.8 K to 108.2 K (+7.44 %) |
Jul 08 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Sell | S | 110.04 | 3,381 | 372,045 | 100,750 | 104.1 K to 100.8 K (-3.25 %) |
Jul 08 2020 | INCY | INCYTE CORP | Stein Steven H | EVP & Chief Medical ... | Buy | M | 88.68 | 3,381 | 299,827 | 104,131 | 100.8 K to 104.1 K (+3.36 %) |
Jul 07 2020 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Option Exercise | M | 64.55 | 15,648 | 1,010,078 | 0 | |
Jul 07 2020 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Option Exercise | M | 64.55 | 905 | 58,418 | 0 | |
Jul 07 2020 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Option Exercise | A | 106.47 | 12,743 | 1,356,747 | 12,743 | |
Jul 07 2020 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Sell | S | 107.32 | 15,648 | 1,679,343 | 156,258 | 171.9 K to 156.3 K (-9.10 %) |
Jul 07 2020 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Buy | M | 64.55 | 15,648 | 1,010,078 | 171,906 | 156.3 K to 171.9 K (+10.01 %) |
Jul 07 2020 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Sell | S | 107.32 | 905 | 97,125 | 156,258 | 157.2 K to 156.3 K (-0.58 %) |
Jul 07 2020 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Buy | M | 64.55 | 905 | 58,418 | 157,163 | 156.3 K to 157.2 K (+0.58 %) |
Jul 07 2020 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Payment of Exercise | F | 107.79 | 404 | 43,547 | 156,258 | 156.7 K to 156.3 K (-0.26 %) |
Jul 07 2020 | INCY | INCYTE CORP | Wenqing Yao | EVP, Head of Discov ... | Payment of Exercise | F | 106.47 | 2,187 | 232,850 | 156,662 | 158.8 K to 156.7 K (-1.38 %) |